Proteomic Reveals Reasons for Acquired Drug Resistance in Lung Cancer Derived Brain Metastasis Based on a Newly Established Multi-Organ Microfluidic Chip Model

Anti-tumor drugs can effectively shrink the lesions of primary lung cancer; however, it has limited therapeutic effect on patients with brain metastasis (BM). A BM preclinical model based on a multi-organ microfluidic chip has been established proficiently in our previous work. In this study, the BM...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Front Bioeng Biotechnol
Hoofdauteurs: Xu, Mingxin, Wang, Yingyan, Duan, Wenzhe, Xia, Shengkai, Wei, Song, Liu, Wenwen, Wang, Qi
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Frontiers Media S.A. 2020
Onderwerpen:
Bioengineering and Biotechnology
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7783320/
https://ncbi.nlm.nih.gov/pubmed/33415100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2020.612091
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items